DAA2292 |
Fc fragment of IgG, low affinity IIa, receptor (CD32) increases with age |
FCGR2A |
104.3% Increase Gene Expression Level |
frontal lobe |
Human |
|
DAA2284 |
Fc fragment of IgG, low affinity IIa, receptor (CD32) increases with age |
FCGR2A |
141.5% Increase Gene Expression Level |
parietal lobe |
Human |
|
DAA2277 |
Fc fragment of IgG, low affinity IIa, receptor (CD32) increases with age |
FCGR2A |
316.4% Increase Gene Expression Level |
hippocampus |
Human |
|
DAA2271 |
Fc fragment of IgG, low affinity IIa, receptor (CD32) increases with age |
FCGR2A |
124.0% Increase Gene Expression Level |
temporal lobe |
Human |
|
DAA2293 |
Fc fragment of IgG, low affinity IIIb, receptor (CD16b) increases with age |
FCGR3B |
52.1% Increase Gene Expression Level |
frontal lobe |
Human |
|
DAA2285 |
Fc fragment of IgG, low affinity IIIb, receptor (CD16b) increases with age |
FCGR3B |
131.1% Increase Gene Expression Level |
parietal lobe |
Human |
|
DAA2278 |
Fc fragment of IgG, low affinity IIIb, receptor (CD16b) increases with age |
FCGR3B |
80.8% Increase Gene Expression Level |
hippocampus |
Human |
|
DAA2161 |
Fc fragment of IgG, low affinity IIIb, receptor (CD16b) increases with age |
FCGR3B |
404.6% Increase Gene Expression Level |
parietal lobe |
Human |
|
DAA2162 |
Fc fragment of IgG, low affinity IIIb, receptor (CD16b) increases with age |
FCGR3B |
261.1% Increase Gene Expression Level |
frontal lobe |
Human |
|
DAA2160 |
Fc fragment of IgG, low affinity IIIb, receptor (CD16b) increases with age |
FCGR3B |
647.0% Increase Gene Expression Level |
hippocampus |
Human |
|
DAA2286 |
Fc fragment of IgG, receptor, transporter, alpha increases with age |
FCGRT |
76.7% Increase Gene Expression Level |
parietal lobe |
Human |
|
DAA2294 |
Fc fragment of IgG, receptor, transporter, alpha increases with age |
FCGRT |
89.3% Increase Gene Expression Level |
frontal lobe |
Human |
|
DAA171 |
FERM and PDZ domain containing 4 |
FRMPD4 |
22.0% Decrease Gene Expression Level |
brain |
Human |
|
DAA356 |
FERM domain containing 3 |
FRMD3 |
3.0% Decrease Gene Expression Level |
skeletal muscle |
Human |
|
DAA553 |
ferredoxin 1 |
FDX1 |
6.0% Decrease Gene Expression Level |
skeletal muscle |
Human |
|
DAA82 |
fibroblast growth factor 12 |
FGF12 |
29.0% Decrease Gene Expression Level |
brain |
Human |
|
DAA83 |
fibroblast growth factor 13 |
FGF13 |
28.0% Decrease Gene Expression Level |
brain |
Human |
|
DAA81 |
fibroblast growth factor 1 (acidic) |
FGF1 |
20.0% Increase Gene Expression Level |
brain |
Human |
|
DAA84 |
fibroblast growth factor 2 (basic) |
FGF2 |
12.0% Increase Gene Expression Level |
brain |
Human |
|
DAA85 |
fibroblast growth factor receptor 3 |
FGFR3 |
13.0% Increase Gene Expression Level |
brain |
Human |
|
DAA303 |
FK506 binding protein 1A, 12kDa |
FKBP1A |
3.0% Decrease Gene Expression Level |
skeletal muscle |
Human |
|
DAA536 |
fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor recep |
FLT1 |
6.0% Decrease Gene Expression Level |
skeletal muscle |
Human |
|
DAA544 |
follistatin |
FST |
8.0% Increase Gene Expression Level |
skeletal muscle |
Human |
|
DAA535 |
forkhead box O1 |
FOXO1 |
6.0% Increase Gene Expression Level |
skeletal muscle |
Human |
|
DAA488 |
fumarate hydratase |
FH |
2.0% Decrease Gene Expression Level |
skeletal muscle |
Human |
|